SLC6A15 and major depressive disorder: In addition, we compare models of NTT4 and B0AT2 (SLC6A15), a close homolog with overlapping substrate and profile expression, whose inhibition is suggested to alleviate anxiety and depression [6], [7], [8], [9], [10], [11].